6 employees
Medeor Therapeutics is a biotechnology company that dedicates to dedicates to the development of personalized cellular immunotherapies.
2012
$57M
from 4 investors over 4 rounds
Medeor Therapeutics, Inc. raised $57M on November 27, 2017
Investors: 6 Dimensions Capital, RA Capital Management, L.P., Vivo Capital and Sofinnova Ventures, Russia technology fund